How does the opioid crisis impact anesthesiologists in managing pain for patients, particularly those with a history of substance abuse or mental health disorders?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 17, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Impact of the Opioid Crisis on Anesthesiologists

Anesthesiologists must fundamentally shift from opioid-centric perioperative pain management to multimodal, opioid-sparing approaches while simultaneously becoming expert managers of patients with opioid use disorder (OUD) who require surgery. 1, 2

Core Clinical Responsibilities Created by the Crisis

1. Rational Opioid Prescribing Framework

Anesthesiologists must apply Maxwell's rational-prescribing approach to every perioperative case, which requires: 1

  • Diagnosing pain mechanisms by evaluating patient symptoms, targetable pain pathways, complete medication history including substance use disorders, and planned procedure characteristics 1
  • Optimizing preoperative conditions by weaning opioids when appropriate and addressing psychological risk factors (anxiety, depression, catastrophic thinking) that correlate with greater postoperative opioid requirements 1
  • Establishing realistic pain goals through shared decision-making rather than promising complete pain elimination—one study showed patients who selected their own opioid quantities chose half the usual prescribed amount yet maintained 90% satisfaction 1

2. Managing Patients on Medications for OUD (MOUD)

Continue all maintenance therapy (methadone or buprenorphine) throughout the perioperative period without interruption. 3, 2 This is non-negotiable because:

  • Mortality risk increases 3.2-fold when patients discontinue methadone treatment, with the four weeks after cessation showing mortality exceeding 30 deaths per 1000 person-years 4
  • Maintenance doses do not provide adequate analgesia for acute pain—this is the most dangerous misconception 5

For patients on methadone: 3

  • Verify and continue the maintenance dose
  • Split daily methadone into 6-8 hour intervals to leverage its shorter analgesic duration (versus 24-hour withdrawal prevention)
  • Add short-acting opioids using scheduled dosing at higher doses and shorter intervals than for opioid-naïve patients
  • Monitor level of consciousness and respiration frequently when adding opioids to methadone therapy 3

For patients on buprenorphine (Suboxone): 5

  • Continue the usual buprenorphine dose perioperatively
  • Add ketamine as an opioid-sparing analgesic (bolus <0.35 mg/kg IV; infusion 0.5-1 mg/kg/h maximum) since it works via NMDA receptor antagonism independent of mu-opioid receptors 5
  • Avoid ketamine only in uncontrolled cardiovascular disease, pregnancy, active psychosis, severe liver dysfunction, high intracranial pressure, or elevated ocular pressure 5

3. Understanding Pain Facilitation in OUD Patients

Patients with OUD have a "syndrome of pain facilitation" where their pain experience is objectively worse than opioid-naïve patients. 3, 4 This occurs through:

  • Subtle withdrawal syndromes, intoxication, withdrawal-related sympathetic arousal, sleep disturbances, and affective changes 3
  • Latent hyperalgesia from long-term opioid exposure involving neuroplastic changes with NMDA receptors 4
  • Lower pain tolerance than peers in remission 3

Critical principle: Never allow pain to reemerge before administering the next dose, as this causes unnecessary suffering and increases tension between patient and treatment team 3

4. Implementing Multimodal Opioid-Sparing Analgesia

Start with aggressive non-opioid interventions as first-line therapy: 3, 6

  • Basic multimodal foundation (start preoperatively or intraoperatively): paracetamol, COX-2 inhibitor or conventional NSAID, dexamethasone, and local anesthetic wound infiltration 6
  • Regional anesthesia techniques: nerve blocks or interfascial plane blocks when anatomically appropriate 6
  • Adjuvant analgesics: gabapentinoids (though caution in older adults due to dizziness and visual disturbance without significant pain benefit), clonidine, intravenous lidocaine infusion, or ketamine infusion 1, 6
  • Neuraxial analgesia during labor should be encouraged for obstetric patients with OUD 1

Evidence for opioid-free anesthesia (OFA): High-quality meta-analysis by Olausson showed OFA associated with significantly lower postoperative opioid consumption and fewer adverse events, though impact on persistent postoperative opioid use (PPOU) remains unclear 1

5. Avoiding Critical Pitfalls

Never use mixed agonist-antagonist opioids (pentazocine, nalbuphine, butorphanol) in patients on methadone or buprenorphine, as these precipitate acute withdrawal syndrome 3, 4

Avoid long-acting opioid formulations (modified-release oral and transdermal) for postoperative pain, as slow onset times make safe titration impossible and increase opioid-induced ventilatory impairment (OIVI) risk 1

Do not rely solely on unidimensional pain scores to guide opioid titration—this increases OIVI risk. Instead, assess patient function and use sedation scoring systems 1, 7

Implement mandatory sedation scoring for all patients receiving opioids, using a system without an 'S' (sleeping) category that allows proper assessment. Target sedation scores <2 to prevent OIVI 1

Avoid "opiophobia"—the exaggerated tendency to undermedicate due to unfounded fears. Undertreating pain decreases responsiveness to opioid analgesics and makes subsequent control more difficult 3

6. Discharge Prescribing Practices

For opioid-naïve patients after routine vaginal delivery: 1

  • First-line: NSAIDs and acetaminophen (unless contraindicated)
  • Consider short course of low-dose opioids only for severe pain unresponsive to non-opioids
  • Severe pain after vaginal delivery is unusual and should prompt evaluation for complications 1

For opioid-naïve patients after cesarean delivery: 1

  • First-line: NSAIDs and acetaminophen
  • Add opioids only if pain persists
  • On discharge, prescribe limited number of opioid pills with counseling about benefits, risks, side effects, and misuse potential 1

Prescribe naloxone to all patients with substance use disorder history due to increased overdose risk 3

7. Special Considerations for Delirium Prevention

Balance adequate analgesia against opioid-related delirium risk in older adults: 1

  • Uncontrolled pain increases delirium risk 9-fold in hip fracture patients 1
  • However, opioid side effects (sedation, hallucination) can precipitate or mimic delirium 1
  • Titrate opioids to minimal effective dose rather than avoiding them entirely—studies show patients receiving <10mg morphine equivalents daily had 5.4-fold increased delirium risk compared to those receiving >10mg 1
  • Avoid pethidine; morphine, fentanyl, and oxycodone are not specifically associated with delirium when properly titrated 1
  • Use multimodal pain management preferentially, including routine paracetamol, NSAIDs when appropriate, and local anesthetic blocks 1

8. Organizational Leadership Role

Anesthesiologists must lead perioperative teams in implementing opioid stewardship programs: 2, 7

  • Develop standardized order sets linking opioid prescriptions to monitoring protocols 1
  • Create multidisciplinary care models involving addiction specialists, behavioral health specialists, and palliative care specialists 3
  • Establish clear treatment agreements documenting pill dispensing, frequency of use, and expected duration 3
  • Evaluate benefits and harms within 1-4 weeks of any dose change 3

The solution to reducing perioperative neurocognitive disorders and opioid-related harm is not in anesthesiologists' hands alone, but we are key members of the multidisciplinary perioperative team and well-placed to lead organizational initiatives. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Pain Management in Patients with Known Addiction

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Methadone Treatment Risks and Side Effects

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Ketamine Use in Patients on Suboxone

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the best approach for post-operative pain management in an asthmatic patient after a Cesarean section?
What is the best alternative pain medication for a postoperative colon cancer patient with inadequate pain relief from Tylenol #3 (acetaminophen and codeine)?
What are the alternatives for pain management after Small Bowel Obstruction (SBO) surgery in a patient with a morphine allergy?
What are the recommended postoperative pain medication options for a former drug addict undergoing surgery?
What are the guidelines for using ibuprofen (Non-Steroidal Anti-Inflammatory Drug (NSAID)) for pain management in patients undergoing surgical procedures, considering their medical history and potential risks?
What are the benefits of using transdermal selegiline (Emsam) cream for a patient with major depressive disorder or Parkinson's disease?
What are the next steps for a pregnant individual with normal beta Human Chorionic Gonadotropin (HCG) and Alpha-Fetoprotein (AFP) levels?
Can a patient with major depressive disorder or Parkinson's disease abuse Emsam (selegiline) patches?
What is the therapeutic dose for gabapentin (Neurontin) in adults with neuropathic pain or epilepsy, considering factors such as renal impairment and age?
What could be causing severe cramping, heavy bleeding, and passage of white membranous tissue with a small blood clot in a female with a history of prolonged menstrual period and strange watery discharge?
What is the best course of action for an elderly female patient with a history of Congestive Heart Failure (CHF) and hypothyroidism, currently taking levothyroxine (thyroid hormone replacement medication) 37.5mcg daily, with an elevated Thyroid-Stimulating Hormone (TSH) level of 10.86?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.